Our Practice
  Our Doctors
  Living with Cancer
  Links of Interest
  FAQ
  Forms
Contact Us
  Clinical Trials
  Community Services
  Know Our Staff
  Patient Feedback

 

 

 

 

 

Colorectal Metastatic

  • AVF3430n, " A Randomized, Open-Label Trail Comparing Two AvastinT (Bevacizumab) - Based Treatment Regimens for the First-Line Treatment of Metastatic Colorectal Cancer."
      • Metastatic or locally advanced and unresectable colorectal cancer.
      • No prior treatment with Avastin
      • No brain mets
      • If patient received prior chemo/radiation must be greater then 12 months out
      • We have no patients enrolled in this study.

« back to Clinical Trials list

 

903-597-CARE • ©Blood and Cancer Center of East Texas • Group M7 design